Taxifolin ameliorates abdominal aortic aneurysm by preventing inflammation and apoptosis and extracellular matrix degradation via inactivating TLR4/NF-κB axis-Reference-Cited by-同舟云学术

Taxifolin ameliorates abdominal aortic aneurysm by preventing inflammation and apoptosis and extracellular matrix degradation via inactivating TLR4/NF-κB axis

Published:2023-06 Issue: Volume:119 Page:110197
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Li Yuanmin,Tao Lingyun,Xu Yawei,Guo Rong^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference46 articles.

1. Infected thoracoabdominal aortic aneurysm related to an implanted long-term arterial catheter for chemotherapy: a case report;Takemoto;J. Med. Case Reports,2021

2. Prevalence of Thoracic Aortic Aneurysms in Patients with Degenerative Abdominal Aortic Aneurysms: Results from the Prospective ACTA Study;Gaudry;Eur. J. Vasc. Endovasc. Surg.,2021

3. Understanding the pathogenesis of abdominal aortic aneurysms;Kuivaniemi;Expert Rev. Cardiovasc. Ther.,2015

4. Clinical practice. Abdominal aortic aneurysms;Kent;N. Engl. J. Med.,2014

5. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm;Chaikof;J. Vasc. Surg.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of natural products and underlying targets for the treatment of aortic aneurysm;Pharmacology & Therapeutics;2024-07

2. The role of transcription factors in the pathogenesis and therapeutic targeting of vascular diseases;Frontiers in Cardiovascular Medicine;2024-04-30

3. Chemokine Receptor 2 Is A Theranostic Biomarker for Abdominal Aortic Aneurysms;2023-11-07